(Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 35.80%-185.32K | 97.95%-6.67K | 27.46%-211.72K | 35.56%-1.4M | 58.81%-436.55K | -72.04%-288.65K | 52.82%-324.94K | -76.16%-291.89K | -97.29%-2.17M | -8.35%-1.06M |
Net income from continuing operations | 168.17%556.44K | 66.44%-270.33K | 23.44%-458.72K | -84.05%-3.02M | 8.20%-796.05K | -145.69%-816.3K | -131.57%-805.51K | -551.51%-599.21K | -7.83%-1.64M | -22.20%-867.19K |
Operating gains losses | -688.88%-106K | ---- | 105.64%2.44K | 127.69%40.35K | ---31.65K | --18K | 0.00%36K | ---43.24K | --17.72K | ---- |
Depreciation and amortization | -23.52%1.67K | -30.42%1.67K | ---- | 130.66%7.52K | -58.79%1.09K | 956.80%2.18K | 1,061.65%2.39K | ---- | 1,015.75%3.26K | --2.64K |
Unrealized gains and losses of investment securities | ---- | ---- | ---- | --72K | ---- | ---- | ---- | ---- | --0 | --0 |
Remuneration paid in stock | -14.15%69.03K | -47.14%42.5K | -47.14%42.5K | -24.91%465.02K | -43.25%223.79K | -22.13%80.41K | 32.22%80.41K | 32.22%80.41K | 1.47%619.24K | 254.41%394.34K |
Other non cashItems | -438.50%-735.49K | 37.35%146.22K | -9.25%145.8K | 6,751.19%531.38K | -61.36%66.84K | 352.72%217.28K | --106.46K | 197.37%160.66K | 147.74%7.76K | 16,891.84%172.96K |
Change In working capital | -86.16%29.04K | -71.30%73.26K | -48.61%56.26K | 142.81%503.76K | 103.52%27.44K | 387.98%209.77K | 158.30%255.3K | 29.64%109.49K | -1,065.75%-1.18M | -96.56%-780.24K |
-Change in receivables | ---- | ---- | ---- | 616.96%65.54K | ---- | ---- | ---- | ---- | 58.14%-12.68K | ---- |
-Change in prepaid assets | ---- | ---- | ---- | 178.63%380.35K | ---- | ---- | ---- | ---- | -502.55%-483.72K | ---- |
-Change in payables and accrued expense | ---- | ---- | ---- | 104.69%30.6K | ---- | ---- | ---- | ---- | -2,588.96%-652.41K | ---- |
-Change in other current liabilities | ---- | ---- | ---- | 197.73%27.27K | ---- | ---- | ---- | ---- | -68.24%-27.9K | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 35.80%-185.32K | 97.95%-6.67K | 27.46%-211.72K | 35.56%-1.4M | 58.81%-436.55K | -13.75%-288.65K | 52.82%-324.94K | -76.16%-291.89K | -97.29%-2.17M | -8.35%-1.06M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -105.35%-9.01K | -229.43%-344.41K | 37.35%-695.1K | -1,796.72%-1.08M | -129.11%-464.53K | 139.79%168.46K | -61.54%266.09K | 54.06%-1.11M | 98.89%-57.17K | 145.60%1.6M |
Net PPE purchase and sale | 98.93%-9.01K | 78.83%-130.19K | -94.94%-613K | -109.54%-2.15M | -74.80%-425.71K | -155.81%-843.54K | -527.24%-615.04K | 11.80%-314.46K | 48.82%-1.03M | 82.34%-243.54K |
Net business purchase and sale | --0 | -272.00%-186K | -193.56%-132.1K | 65.85%-212.5K | 77.39%-127.5K | --0 | ---50K | 22.95%-45K | -94.44%-622.22K | ---563.82K |
Net investment purchase and sale | --0 | --0 | --0 | -17.64%1.25M | -99.92%1.81K | 150.00%1M | 33.33%1M | 62.50%-750K | 154.28%1.52M | 231.66%2.37M |
Net other investing changes | ---- | 59.02%-28.22K | --50K | -58.90%30K | 163.23%86.87K | --12K | -272.17%-68.87K | ---- | --73K | --33K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -105.35%-9.01K | -229.43%-344.41K | 37.35%-695.1K | -1,796.72%-1.08M | -129.11%-464.53K | 139.79%168.46K | -61.54%266.09K | 54.06%-1.11M | 98.89%-57.17K | 145.60%1.6M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 616.69%500K | -14.16%-66.23K | 100.89%1.27K | -37.87%1.19M | -20.81%1.49M | -282.01%-96.77K | -58.01K | -829.66%-141.62K | -79.14%1.91M | -54.58%1.88M |
Net issuance payments of debt | --500K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net common stock issuance | ---- | ---- | --100K | -20.96%1.53M | ---- | ---- | ---- | --0 | -77.94%1.94M | ---- |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -63.98%219.5K | 104.00%180K |
Interest paid (cash flow from financing activities) | --0 | -16.33%-65.68K | 31.68%-96.19K | -36.78%-296.97K | 98.64%-2.95K | ---96.77K | ---56.46K | ---140.8K | ---217.13K | ---217.13K |
Net other financing activities | ---- | 64.82%-545 | -208.11%-2.55K | -79.67%-44.21K | -81.58%-41.83K | ---- | ---1.55K | 96.28%-826 | 88.22%-24.6K | 83.92%-23.04K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 616.69%500K | -14.16%-66.23K | 100.89%1.27K | -37.87%1.19M | -20.81%1.49M | -282.01%-96.77K | ---58.01K | -829.66%-141.62K | -79.14%1.91M | -54.58%1.88M |
Net cash flow | ||||||||||
Beginning cash position | -94.05%59.66K | -58.56%463.62K | -48.56%1.37M | -10.48%2.66M | 213.29%785.04K | 163.05%1M | 196.21%1.12M | -10.48%2.66M | 11,303.47%2.97M | -92.46%250.58K |
Current changes in cash | 240.89%305.67K | -245.67%-403.96K | 41.27%-905.56K | -314.65%-1.29M | -75.77%584.14K | -66.46%-216.96K | -3,759.94%-116.86K | 40.60%-1.54M | -110.58%-311.75K | 793.62%2.41M |
End cash Position | -53.46%365.34K | -94.05%59.66K | -58.60%463.62K | -48.56%1.37M | -48.56%1.37M | 213.29%785.04K | 163.05%1M | 196.48%1.12M | -10.48%2.66M | -10.48%2.66M |
Free cash from | 82.84%-194.33K | 85.44%-136.86K | -36.02%-824.73K | -11.11%-3.55M | 33.84%-862.26K | -94.03%-1.13M | -19.47%-939.99K | -16.11%-606.35K | -2.86%-3.2M | 44.71%-1.3M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data